Rocket Pharmaceuticals
RCKT
$22.77
Share price
1.07%
Change (1 day)
24.36%
Change (1 year)
Categories
Rocket Pharmaceuticals (RCKT) - P/B ratio
P/B ratio as of May 2024 : 4.15
According to Rocket Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 4.15.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Rocket Pharmaceuticals - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.49 | 74.35% |
| 2022-12-31 | 3.15 | 1.7% |
| 2021-12-31 | 3.09 | -52.56% |
| 2020-12-31 | 6.52 | 60.76% |
| 2019-12-31 | 4.06 | 17.52% |
| 2018-12-31 | 3.45 | 132.05% |
| 2017-12-31 | 1.49 | -33.75% |
| 2016-12-31 | 2.25 | -18.39% |
| 2015-12-31 | 2.75 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.81 | -32.37% | 🇺🇸 USA |